- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2012-003524-21. Displaying page 1 of 1.
|EudraCT Number: 2012-003524-21||Sponsor Protocol Number: D4880C00003||Start Date*: 2013-11-04|
|Sponsor Name:MedImmune, LLC|
|Full Title: A Phase 2b, Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Second- or Third-line Treatment of Subjects with Unresectable Pleural or Peritoneal Malignant Mesothelioma|
|Medical condition: unresectable pleural or peritoneal malignant mesothelioma|
|Population Age: Adults, Elderly||Gender: Male, Female|
|Trial protocol: DE (Prematurely Ended) BE (Completed) GB (Ongoing) HU (Ongoing) IT (Ongoing) DK (Completed) NL (Ongoing) ES (Completed) FR (Completed) PL (Completed)|
|Trial results: (No results available)|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.